These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 39215366)

  • 21. Therapeutic efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in a high-transmission area in northwest Ethiopia.
    Teklemariam M; Assefa A; Kassa M; Mohammed H; Mamo H
    PLoS One; 2017; 12(4):e0176004. PubMed ID: 28445503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal timing of primaquine to reduce Plasmodium falciparum gametocyte carriage when co-administered with artemether-lumefantrine.
    Shekalaghe S; Mosha D; Hamad A; Mbaga TA; Mihayo M; Bousema T; Drakeley C; Abdulla S
    Malar J; 2020 Jan; 19(1):34. PubMed ID: 31964380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrocardiographic safety evaluation of extended artemether-lumefantrine treatment in patients with uncomplicated Plasmodium falciparum malaria in Bagamoyo District, Tanzania.
    Mhamilawa LE; Wikström S; Mmbando BP; Ngasala B; Mårtensson A
    Malar J; 2020 Jul; 19(1):250. PubMed ID: 32664948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study.
    Vaughan-Williams CH; Raman J; Raswiswi E; Immelman E; Reichel H; Gate K; Knight S
    Malar J; 2012 Dec; 11():434. PubMed ID: 23272998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Ethiopia.
    Jima D; Tesfaye G; Medhin A; Kebede A; Argaw D; Babaniyi O
    East Afr Med J; 2005 Aug; 82(8):387-90. PubMed ID: 16261913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2019.
    Ngasala BE; Chiduo MG; Mmbando BP; Francis FT; Bushukatale S; Makene T; Mandara CI; Ishengoma DS; Kamugisha E; Ahmed M; Mahende MK; Kavishe RA; Muro F; Molteni F; Reaves E; Kitojo C; Greer G; Nyinondi S; Kabula B; Lalji S; Chacky F; Njau RJ; Warsame M; Mohamed A
    Malar J; 2024 Apr; 23(1):101. PubMed ID: 38594679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in four malaria endemic states of India.
    Krishna S; Mishra S; Tiwari P; Vishwakarma AK; Khandai S; Shrivastava S; Verma AK; Tiwari S; Barman H; Jhariya S; Tiwari P; Tidgam AS; Varun BM; Singh S; Yerane N; Tembhurne CR; Mandavi PL; Tekam SS; Malik M; Behera KP; Jayswar H; Sonwani K; Diggikar MS; Pradhan MM; Khasotiya SS; Kumar A; Dhingra N; Bustos MDG; Christophel EM; Ringwald P; Kumari R; Shukla MM; Singh N; Das A; Bharti PK
    Malar J; 2021 May; 20(1):229. PubMed ID: 34020652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of artemether-lumefantrine therapy for the treatment of uncomplicated Plasmodium falciparum malaria in Southwestern Ethiopia.
    Mekonnen SK; Medhin G; Berhe N; Clouse RM; Aseffa A
    Malar J; 2015 Aug; 14():317. PubMed ID: 26271736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Open-label trial with artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria three years after its broad introduction in Jimma Zone, Ethiopia.
    Eshetu T; Abdo N; Bedru KH; Fekadu S; Wieser A; Pritsch M; Löscher T; Berens-Riha N
    Malar J; 2012 Jul; 11():240. PubMed ID: 22824059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
    Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
    Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artemether-Lumefantrine Efficacy for the Treatment of Uncomplicated
    Olivera MJ; Guerra AP; Cortes LJ; Horth RZ; Padilla J; Novoa J; Ade MP; Ljolje D; Lucchi NW; Marquiño W; Renteria M; Yurgaky W; Macedo de Oliveira A
    Am J Trop Med Hyg; 2020 May; 102(5):1056-1063. PubMed ID: 32100686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014.
    Paczkowski M; Mwandama D; Marthey D; Luka M; Makuta G; Sande J; Ali D; Troell P; Mathanga DP; Gutman J
    Malar J; 2016 Apr; 15():236. PubMed ID: 27113085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial.
    Peto TJ; Tripura R; Callery JJ; Lek D; Nghia HDT; Nguon C; Thuong NTH; van der Pluijm RW; Dung NTP; Sokha M; Van Luong V; Long LT; Sovann Y; Duanguppama J; Waithira N; Hoglund RM; Chotsiri P; Chau NH; Ruecker A; Amaratunga C; Dhorda M; Miotto O; Maude RJ; Rekol H; Chotivanich K; Tarning J; von Seidlein L; Imwong M; Mukaka M; Day NPJ; Hien TT; White NJ; Dondorp AM
    Lancet Infect Dis; 2022 Jun; 22(6):867-878. PubMed ID: 35276064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya.
    Juma EA; Obonyo CO; Akhwale WS; Ogutu BR
    Malar J; 2008 Dec; 7():262. PubMed ID: 19102746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania.
    Mwaiswelo R; Ngasala BE; Jovel I; Gosling R; Premji Z; Poirot E; Mmbando BP; Björkman A; Mårtensson A
    Malar J; 2016 Jun; 15():316. PubMed ID: 27287612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
    Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
    Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ethiopia: a systematic review and meta-analysis.
    Abamecha A; Yilma D; Adissu W; Yewhalaw D; Abdissa A
    Malar J; 2021 May; 20(1):213. PubMed ID: 33957925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
    Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
    Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.